There is no single test that can diagnose or rule out long COVID. No blood test, imaging scan, or lab panel has been approved for this purpose, and routine results like bloodwork, chest X-rays, and heart tracings often come back completely normal in people living with the condition. Long COVID remains what’s called a clinical diagnosis, meaning doctors identify it based on your symptoms, your history of COVID-19 infection, and the exclusion of other possible causes.
Why a Standard Test Doesn’t Exist Yet
Long COVID affects multiple organ systems and shows up differently from person to person. Some people develop crushing fatigue and brain fog. Others have chest pain, shortness of breath, or a racing heart when they stand up. Still others lose their sense of taste or smell for months. This wide range of symptoms, combined with the fact that the underlying biology is still being mapped, makes it extremely difficult to pin the condition down with a single lab value.
The CDC states plainly that no laboratory test can definitively diagnose long COVID or distinguish it from conditions with different causes. A positive COVID test or antibody result can help confirm a past infection, but it isn’t required for a diagnosis. Many people who develop long COVID were never formally tested during their initial illness, especially during the early waves of the pandemic.
How Doctors Actually Diagnose It
Because there’s no definitive test, clinicians piece together a diagnosis from several sources. The process typically starts with a detailed review of your medical history: when you had COVID (or suspect you did), what symptoms appeared afterward, and how those symptoms have changed over time. Long COVID symptoms can emerge right after the initial illness, develop after a period of feeling better, or even follow an infection you never realized you had.
From there, your doctor will likely order standard labs, not to confirm long COVID, but to rule out other explanations. A complete blood count, metabolic panel, thyroid function test, and lipid panel can help exclude anemia, diabetes, thyroid disease, and other conditions that mimic long COVID symptoms like fatigue and brain fog. The point of these tests is elimination. If everything comes back normal and your symptoms started after a COVID infection, long COVID becomes the most likely explanation.
Specialized long COVID clinics, including those run by the VA, evaluate patients using structured symptom checklists that cover the most common problem areas: fatigue and activity intolerance, cognitive impairment, headaches, shortness of breath, chest pain, cough, anxiety and depression, loss of taste or smell, and dysfunction of the autonomic nervous system (which controls things like heart rate and blood pressure). These clinics also use functional scales that measure your overall vitality and well-being to track how the condition affects daily life over time.
Tests That Investigate Specific Symptoms
While no single test diagnoses long COVID itself, targeted testing can identify specific problems the condition causes. This is where things get more granular, and the tests your doctor orders depend entirely on which symptoms you’re experiencing.
If you have a racing heartbeat or dizziness when standing, a tilt table test can check for postural orthostatic tachycardia syndrome (POTS), a form of autonomic dysfunction that’s become closely associated with long COVID. During this test, you lie on a table that tilts you upright while monitors track your heart rate and blood pressure. In one study of long COVID patients with these symptoms, about 21% met the criteria for POTS on tilt table testing, though notably, the majority had symptoms of dizziness and lightheadedness without measurable abnormalities on the test. A normal result doesn’t mean you’re fine; it means the specific threshold for a POTS diagnosis wasn’t met.
For persistent chest pain or shortness of breath, cardiac MRI can reveal inflammation that standard tests miss entirely. In one study of patients with ongoing cardiac symptoms after COVID, 54% showed signs of swelling in the heart muscle and 31% had scarring. Even among otherwise healthy elite soldiers who had only mild COVID, 29% had heart muscle abnormalities on cardiac MRI. Specialized imaging like PET scans can also detect reduced blood flow in the tiny vessels of the heart, a problem called coronary microvascular dysfunction that appears more frequently in post-COVID patients than in matched controls.
For cognitive symptoms like brain fog, neurocognitive testing can document measurable changes in memory, attention, and processing speed. The NIH’s large-scale RECOVER study uses a tiered approach: everyone gets basic assessments, but people with neurological symptoms may undergo advanced brain imaging with MRI or detailed cognitive evaluations.
Blood Markers Under Investigation
Researchers are actively searching for blood-based biomarkers that could eventually lead to a diagnostic test. Several promising signals have emerged, though none are ready for clinical use.
One line of research focuses on immune system exhaustion. A study from the NIH’s RECOVER initiative found that people with long COVID showed persistent activation of inflammatory pathways and signs of T-cell exhaustion more than six months after their initial infection. T cells are a critical part of your immune defense, and when they become “exhausted,” they stop functioning effectively. This pattern, chronic inflammation paired with an immune system that’s simultaneously overactive and worn out, appeared consistently across multiple types of analysis.
Other researchers have zeroed in on specific inflammatory proteins in the blood. One study found that a signaling molecule called IL-8 was elevated in long COVID patients with neurological symptoms compared to both recovered COVID patients and healthy controls. Another inflammatory marker showed strong predictive accuracy for identifying people who had been infected with COVID, though it was less specific to long COVID itself.
Perhaps the most striking findings involve tiny particles shed by nerve cells into the bloodstream. Researchers found that long COVID patients with neurological symptoms had significantly elevated levels of proteins associated with neurodegeneration, including types of amyloid and tau proteins more commonly linked to Alzheimer’s disease. These markers were measurably higher than in both healthy people and those who recovered from COVID without lasting symptoms.
Microclot formation and blood vessel damage are also being studied as potential contributors, particularly for symptoms involving fatigue and exercise intolerance. But all of these markers remain in the research phase. None have been validated in large enough studies or standardized into a test your doctor can order.
What a Diagnosis Actually Looks Like
In practice, getting a long COVID diagnosis involves a conversation more than a lab result. Your doctor documents the diagnosis using a specific medical code (U09.9, for “post-COVID-19 condition”) along with codes for each individual symptom or condition you’re experiencing. This coding exists not because there’s a test that triggered it, but because a clinician evaluated your history and symptoms and determined long COVID was the best explanation.
A prior positive COVID test strengthens the case but isn’t strictly necessary. Many doctors will accept a history of probable infection, especially if you had classic symptoms during a known surge period. The American Medical Association has acknowledged the gap in diagnostic tools, noting that physicians must rely on comprehensive evaluations and careful exclusion of other possible causes.
If you suspect you have long COVID, the most productive path is a visit to a primary care provider who can start the process of ruling out other conditions and, if needed, refer you to a specialized long COVID clinic. These clinics coordinate testing across multiple specialties rather than forcing you to navigate referrals on your own. The NIH RECOVER initiative uses a structured approach where initial screening identifies which organ systems need deeper investigation, then directs patients toward advanced imaging, autonomic testing, or other specialized evaluations based on their specific symptom profile.